Israel's Largest Pharmacy Chain May Buy Teva Pharm Plant

Super-Pharm is reportedly in talks to buy Teva's Ashdod plant, retaining the site's 70 employees
Dec. 26, 2017

Super-Pharm, Israel's largest pharmacy chain, is reportedly in talks to buy Teva's Ashdod plant.

Sources say that the pharmacy chain may pay approximately$17 million to 23 million and is prepared to commit to continue employing the factory’s 70 workers.

Teva had already announced plans to cut down its workforce by more than a quarter, giving up various plants in the process in order to pay off its nearly $35 billion debt.

This Teva plant has been used to prepare liquid medications such as antibiotics and chemotherapy.

Read the Reuters report

Sign up for our eNewsletters
Get the latest news and updates